Abstract:Randomized trials showed equivalent survival between breast conserving surgery with radiation (BCT) and mastectomy in early stage breast cancer. Retrospective studies have evolved the unique prognosis and response to therapy for each breast cancer subtype. Elderly breast cancer patients comprise a cohort with unique outcomes and limited published findings analyzing the effect of subtype. The purpose of this study is to use the Surveillance, Epidemiology, and End Result (SEER) database to compare breast conserving surgery with radiation therapy (BCT) and mastectomy outcomes for elderly women with each tumor subtype. Cases diagnosed from 2010-2012 were obtained from the SEER database with inclusion criteria for women 70 years old and above, diagnosed with T1-2N0M0 as well as known status of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2). They were grouped for analysis as: HR+/HER2-, HR-/HER2+, HR+/HER2+, and triple-negative (TN). Kaplan-Meier and Cox multivariate regression analysis of overall survival (OS) and cause specific survival (CSS) was performed. A total of 13736 patients were identified, of whom 9652 (70.3%) received BCT and 4084 (29.7%) underwent mastectomy. Patient distribution was 82.8% HR+/HER2- , 2.2% HR-/HER2+ , 5.9% HR+/HER2+and 9.1% TN. With a median follow-up of 20 months (range, 1-35 months), women undergoing BCT had improved OS (98.0%VS 95.0%, P<0.001) and CSS (99.7%VS 98.8%, P<0.001) when compared to women with mastectomy. When the patients were subdivided by tumor subtypes, the BCT group continued to show better OS and CSS compared with the mastectomy group in all of the subgroups except HR+/HER2+. In the subtype group of HR+/HER2-, OS and CSS was 98.2% and 99.8% after BCT and 95.8% and 99.3% after mastectomy (both P<0.001). The results were similar for HR-/HER2+ and TN subgroups favoring BCT group. However, no significant difference in CSS was observed between BCT and mastectomy for HR+/HER2+ subgroup (P = 0.873). Cox Regression analysis showed that BCT resulted in OS (HR 0.49, 95% CI 0.40 – 0.61, P<0.001) and CSS (HR 0.41, 95% CI 0.26-0.65, P<0.001) better than that of mastectomy. The CSS benefit with BCT compared to mastectomy was greater among HR+/HER2-subgroup (HR 0.4, 95% CI 0.21–0.77) than among TN subgroup (HR 0.45, 95% CI 0.21–0.99); however, this trend was not observed among the other two subgroups. Elderly patients (≥70 years old) with early stage breast cancer who underwent BCT have better CSS and OS compared with those treated with mastectomy alone. These results provide confidence that BCT is an effective alternative to mastectomy for elderly patients with early stage disease regardless of tumor subtypes. Further investigation is warranted.

Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis

Survival Outcomes after Breast-Conserving Therapy Compared with Mastectomy for Patients with Early-Stage Metaplastic Breast Cancer: a Population-Based Study of 2412 Patients

Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis

Supplementary Material For: Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis

Higher 10-Year Survival with Breast-Conserving Therapy over Mastectomy for Women with Early-Stage (I-II) Breast Cancer: Analysis of the CDC Patterns of Care Data Base

Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis

Does Breast-Conserving Surgery with Radiotherapy have a Better Survival than Mastectomy? A Meta-Analysis of More than 1,500,000 Patients

The Impact of Tumor Subtypes on Outcomes in Elderly Patients (≥70 Years Old) with Early-Stage Breast Cancer: A Population-Based Study

Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.

Breast Conservation Therapy for Stage I or Stage II Breast Cancer: a Meta-Analysis of Randomized Controlled Trials

Breast-conserving Therapy and Modified Radical Mastectomy for Primary Breast Carcinoma: a Matched Comparative Study.

Survival Outcomes of Breast-Conserving Surgery Versus Mastectomy in Locally Advanced Breast Cancer Following Neoadjuvant Chemotherapy: A Meta-Analysis

Breast-Conserving Therapy Has Better Prognosis for Tumors in the Central and Nipple Portion of Breast Cancer Compared with Mastectomy: A SEER Data-Based Study

Comparisons of breast conserving therapy versus mastectomy in young and old women with early-stage breast cancer: long-term results using propensity score adjustment method

Breast conserving surgery versus mastectomy: overall and relative survival—a population based study by the Danish Breast Cancer Cooperative Group (DBCG)

Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis

The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study

Breast surgery for young women with early-stage breast cancer Mastectomy or breast-conserving therapy?